메뉴 건너뛰기





Volumn 22, Issue 3, 2008, Pages 261-272

Review and clinical perspectives for the use of infliximab in ulcerative colitis

(20)  Panaccione, Remo a   Fedorak, Richard N b   Aumais, Guy c   Bernard, Edmond Jean c   Bernstein, Charles N d   Bitton, Alain e   Croitoru, Ken f   Dieleman, Levinus A b   Enns, Robert g   Feagan, Brian G h   Franchimont, Denis e   Greenberg, Gordon R i   Griffiths, Anne Marie i   Marshall, John K f   Pare, Pierre j   Patel, Sunil k   Penner, Robert b   Render, Craig b   Seidman, Ernest e   Steinhart, A Hillary i  


Author keywords

Drug administration schedule; Immunomodulatory agents; Inflammatory bowel disease; Infliximab; Monoclonal antibodies; Ulcerative colitis

Indexed keywords

ANTIDIARRHEAL AGENT; AZATHIOPRINE; BETAMETHASONE; CORTICOSTEROID; CYCLOSPORIN; GLUCOCORTICOID; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHYLPREDNISOLONE; PARACETAMOL; PLACEBO; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID; SULFAMETHOXAZOLE; TRIMETHOPRIM;

EID: 43549098033     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/493405     Document Type: Review
Times cited : (10)

References (86)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.